Back to results
US 8,912,225 B2Granted
VEGF inhibition
AssigneePitney Pharmaceuticals Pty Limited
InventorsDavid L. Morris, Mohammad H. Pourgholami
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for inhibiting VEGF production or secretion in a subject comprising administering to the subject an effective amount of a compound of Formula I. The invention also provides methods for the treatment or prevention of conditions associated with abnormal levels of VEGF production or secretion.
Claims2
A method for treating malignant ascites caused by ovarian cancer in a subject, the method comprising administering to the subject, who is suffering from malignant ascites caused by ovarian cancer, an effective amount of an albendazole
- wherein the effective amount is in the range of about 10 mg to about 200 mg per kg body weight per 24 hours, and wherein the administration is intracavitary.
Dependencies are inferred from the claim text.